Sign In
Buy TLT
$85.31
-0.340 (-0.397%)
At Close: Jun 03, 2026
Ruvidar Demonstrates 7 Year Complete Response
07:00am, Monday, 07'th Apr 2025
Patient Diagnosed with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In-Situ Treated Once with Light-Activated Ruvidar(TM) Demonstrates 7 Year Complete Response Toronto, Ontario--(News
TLT: Two Positives From The Tariffs
01:47pm, Friday, 04'th Apr 2025
Reciprocal tariffs announced by President Trump have caused significant market shifts, with the iShares 20+ Year Treasury Bond ETF breaking to a new 2025 high. Long-term yields are influenced by infla
New Tariff Worsens Trade War Fears: 5 Safe Haven ETFs to Buy
11:25am, Thursday, 03'rd Apr 2025
Here, we highlight five safe-haven ETFs that investors should consider adding to their portfolios as trade fears continue to escalate.
Trade Tracker: Joe Terranova adds to his TLT position
01:49pm, Wednesday, 02'nd Apr 2025
Joe Terranova, Senior Managing Director for Virtus Investment Partners, joins CNBC's "Halftime Report" to explain why he's adding to his TLT position for the third time.
Trade Tracker: Joe Terranova buys more of TLT
02:40pm, Monday, 31'st Mar 2025
Joe Terranova, Senior Managing Director for Virtus Investment Partners, joins CNBC's "Halftime Report" to explain why he's buying more of TLT.
SPY Vs TLT: Trump Put Likely To Mitigate Stagflation Risks
08:00am, Monday, 31'st Mar 2025
Market volatility continues driven by Trump's tariff policy, with the S&P 500 nearing correction territory as recession risks rise, indicating that we are not out of the woods yet. Tariff-driven infla
How To Strategically Invest $100,000 In A Volatile Market - Part 2
08:15am, Friday, 28'th Mar 2025
The market is experiencing some hiccups, with plenty of uncertainties looming, making gradual investment over 3–6 months advisable for long-term investors. The article is part 2 of our previous arti
Trade Tracker: Joe Terranova buys the TLT
01:10pm, Monday, 24'th Mar 2025
Joe Terranova, Senior Managing Director for Virtus Investment Partners, joins CNBC's "Halftime Report" to explain why he's buying the Treasury Bond ETF.
Ruvidar Effective in the Treatment of Herpes
07:00am, Monday, 24'th Mar 2025
Ruvidar(TM) demonstrates higher efficacy in the treatment of Herpes Simplex Virus, Type 1 versus the standard of care treatments Acyclovir and Abreva in a preclinical animal model. Toronto, Ontario--(
Chart Of The Day: Buy Or Sell This 'Mystery' Fund?
07:30am, Friday, 21'st Mar 2025
It's easy to make a case against US Treasuries. Yet, from a technical perspective, there's a lot to like. What message is the “mystery” MoneyShow Chart of the Day sending?
3 ETFs Every Investor Needs to Hedge S&P 500 Volatility
07:13am, Friday, 21'st Mar 2025
There are deeper levels to the big machine, the financial market, where investors need to understand the cogs that make it run and when one of them is starting to speed up or slow down in relation to
Northrop Grumman (NOC), iShares Treasury Bond ETF (TLT) And Barrick Gold (GOLD) Are 3 of the Safest Stocks to Buy Now
09:41am, Thursday, 20'th Mar 2025
A market correction can be unsettling for investors, but it also presents opportunities to buy high-quality stocks at a discount.
Theralase Technologies Inc. (TLTFF) Q4 2024 Earnings Call Transcript
01:51pm, Wednesday, 19'th Mar 2025
Theralase Technologies Inc. (OTCQX:TLTFF) Q4 2024 Earnings Conference Call March 19, 2025 11:00 AM ET Company Participants Matthew Perraton - Chairman of the Board Kristina Hachey - Chief Financial Of
The Big 3: FXI, GS, TLT
12:30pm, Wednesday, 19'th Mar 2025
Chinese mega caps and American financials take the focus of today's Big 3. @Theotrade's Don Kaufman explains why he's bearish on the iShares China Large-Cap ETF (FXI) and Goldman Sachs (GS) while main
TLT Vs. EDV: Why I Prefer EDV And How I Allocate It Dynamically
03:00am, Saturday, 15'th Mar 2025
A 40-60 bond-equity allocation model, or other fixed allocation models, could miss critical market junctures. This is why I use a dynamic allocation method based on bonds' valuations relative to other
